SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-449282
Filing Date
2012-11-02
Accepted
2012-11-02 16:52:46
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d413292d10q.htm 10-Q 592952
2 SECTION 302 CEO CERTIFICATION d413292dex311.htm EX-31.1 9212
3 SECTION 302 CFO CERTIFICATION d413292dex312.htm EX-31.2 9393
4 SECTION 906 CEO CERTIFICATION d413292dex321.htm EX-32.1 3550
5 SECTION 906 CFO CERTIFICATION d413292dex322.htm EX-32.2 3764
  Complete submission text file 0001193125-12-449282.txt   4724967

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT thld-20120930.xml EX-101.INS 801377
7 XBRL TAXONOMY EXTENSION SCHEMA thld-20120930.xsd EX-101.SCH 40472
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thld-20120930_cal.xml EX-101.CAL 48149
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thld-20120930_def.xml EX-101.DEF 224187
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE thld-20120930_lab.xml EX-101.LAB 332141
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thld-20120930_pre.xml EX-101.PRE 261374
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32979 | Film No.: 121177423
SIC: 2834 Pharmaceutical Preparations